Katherine Bowman is a Senior Program Officer with the Board on Life Sciences of the U.S. National Academies of Sciences, Engineering, and Medicine. Her activities focus on the potential implications of developments in science and technology. She is currently co-director of the International Commission on the Clinical Use of Human Germline Genome Editing with colleagues at the Royal Society and was director of the 2017 report Human Genome Editing: Science, Ethics, and Governance. Other recent studies in which she has been involved include Safeguarding the Bioeconomy (2020), Biodefense in the Age of Synthetic Biology (2018), and Microbiomes of the Built Environment: A Research Agenda for Indoor Microbiology, Human Health, and Buildings (2017). She also takes part in international activities, many conducted collaboratively with the InterAcademy Partnership, that explore advances in science and their potential impacts for biological and chemical security. She received her Ph.D. in Biomedical Engineering from Johns Hopkins University.
Senior Program Officer
Board on Life Sciences of the U.S. National Academies of Sciences, Engineering, and Medicine